×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Volver a Agenda
Session 4, Track B: Decentralized Clinical Trials – Canada’s First Case Study and Next Steps
Session Chair(s)
Stephanie Anderson
Associate Director, Regulatory Affairs
Intrinsik Corp., Canada
The global COVID-19 pandemic has catalyzed substantial advancements in the establishment and execution of decentralized clinical trials (DCTs) in Canada. This session will offer a glimpse into the experiences and findings from Canada’s first fully decentralized trial. Furthermore, we will delve into a proposed framework for hybrid DCTs, sharing experiences to date, lessons learned, and a vision for the future. Keeping our commitment to patient-centricity, we will also discuss the perceived advantages and challenges of DCTs from the perspectives of patients, caregivers, and their families.
Learning Objective : At the conclusion of this session, participants should be able to:- Describe different DCT models and understand methods to implement them
- Discuss the advantages and challenges with implementing DCTs
- Recognize the patient perspective when implementing DCTs
Speaker(s)
CRAFT Hybrid DCT Model and Experience to Date
Representative Invited
BC Cancer, Canada
¿Tiene una cuenta?